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Summary: Fibronectin (Synonyms: cold-insoluble globulin, antigelatin factor) is a cell surface glycoprotein. It has
been shown that remarkably large amounts of fibronectin are present in human plasma. Owing to the difficult and
expensive radioimmunoassays, only a few reports on the relation of fibronectin and human diseases have so far been
published.
In this communication a rapid and easily handled immunoassay, using the light scattering effect, is described. The
first results on the measurement of fibronectin concentrations in the plasma of patients with chronic active liver
diseases are reported.
Schnelle Bestimmung von Fibronectin durch Lasernephelometrie;
Fibronectinkonzentrationen im Plasma bei Erkrankungen des Menschen, L Mitteilung
Zusammenfassung: Fibronectin (Synonyma: Kälteunlösliches Globulin, j3-Kryoglobulin, Antigelatine-Faktor) ist ein
Glykoprotein von Zelloberflächen. Im menschlichen Plasma sind hohe Konzentrationen an Fibronectin nachweisbar.
Wegen des schwierigen und kostenintensiven Nachweises durch Radioimmunoassay sind bislang nur wenige Berichte
über Fibronectinkonzentrationen im Plasma von Patienten bekannt geworden. In dieser Mitteilung wird ein schneller
und einfacher Immunoassay durch Lasernephelometrie beschrieben. Über erste Ergebnisse von Patienten mit chro-
nisch aktiven Leberkrankheiten wird berichtet.
Introduction There have been recent reports on fibronectin as a
protein of connective tissue matrix, and increased levels
Glycoproteins are characteristic constituents of mem-
 of fibronectin have been reported in fibrotic processes
branes in mammalian cells. Some structural glycoproteins ^ ^
 Spm(? authors suggest that increased fibronectin
are associated with the cell membrane. Their physio- concentrations in the plasma of patients with accelerated
logical function and their role in the pathological status
 connective tissue metabolism would reflect the activity
of cells are not completely elucidated.
 pf fibropiasia (3), but so far there are no reports con-
One of the cell surface glycoproteins is fibronectin cerning fibronectin and connective tissue diseases.
(Synonym: coldJnspluble globulin) (for reviews see Lc.
(1 2)) which is identical or closely related to the anti- Up to now only time-consuming gel diffusion assays (7)
gelatin'factor (3). In recent years interest has been or difficult and expensive immunoassays (8) have been
focussed on fibronectin, because cultured proliferating used to measure fibronectin concentrations in bio-
or vims-transformed fibroblasts as well as smooth muscle
cells and endothelial cells secrete fibrpnectin into^the ij supported by Deutsche Forschungsgemeinschaft, Bonn-Bad
culture medium (4). Godesberg (SFB104, A4).
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logical fluids. This may be why no intensive study has
been made of plasma concentrations of fibronectin in
patients with various diseases. In this communication we
describe a rapid and easily handled determination of
fibronectin by laser nephelometry, using a monospecific
antibody.
Material and Methods
Preparation of fibronectin
Fibronectin was purified from human plasma, using adsorption
chromatography with coupled denaturated collagen type I, as
described previously (3, 9).
Antibodies were raised against fibronectin in rabbits (3). The
resulting anti-human fibronectin rabbit serum was compared
with an anti-human fibronectin rabbit serum from Behring-
Werke Marburg, FRG. Fibronectin and monospecific antibodies
were produced in the same way. Purity was shown by formation
of a single band in various gel electrophoretic systems. Both
antisera were tested against fibrinogen, and no reaction was ob-
served.
Laser nephelometric immunoassay
Basic principles of laser nephelometry are described elsewhere
(10). The nephelometer of Behring-Werke-MesserrGriesheim,
FRG, was used in the present studies.
A plasma pool was made of 20 healthy male and female persons
(20-50 years of age). Blood was collected in sodium citrate and
plasma was separated by centrifugation at room temperature.
Plasma was cleared by Frigen® (Hoechst AG, Frankfurt, FRG).
A standard plasma (Behring-Werke) with a known concentration
of fibronectin was also used. Antisera were cleared by filtration
through a Millipore filter (Millipore S. A., Molsheim, France).
Both methods for plasma clearing were without significant
effects on the fibronectin concentration.
Dilution series both for antisera and plasma were prepared as
described in Figure 1 and 2. The output of the nephelometer
did not exceed 0.5 volt for either the antisera (dilution 1:2), or
plasma (dilution 1:5).
The final test consists of:
100 μΐ plasma, dilution 1:10 in 0.15 mol/1 NaCl
200 μΐ antiserum, dilution 1:5 (Behring-Werke); 1:10 (own
preparation) in 0.15 mol/1 NaCl. Using this dilution no output
of the nephelometer was observed with plasma or ahtiserum
blanks. Reaction time was 60 min.
Determination of serum activity of N-acetyl- -glucosaminidase
and histological estimation of fibrosis in liver biopsy specimens
of patients with chronic active liver diseases were performed as
previously described (11).
Results
Plasma fibronectin reacts with corresponding antibodies,
visible by the measurable turbidity of the immuno-
precipitate in the reaction mixture. The immune reac-
tion is concentration-dependent in a nearly linear range
from 0.6 to 3.0 mg/dl fibronectin (antiserum dilution
1:5, antiserum Behring-Werke, and 1:10 for tjhe self-
prepared anti-human fibronectin serum). Dilution experi-
ments with the antisera are demonstrated in figure 1.
Reaction capacity is sufficient after a dilution up to
1:16 (1:32). For clinical use, a dilution of the plasma
specimens was made 1:10 in 0.15 mol/1 NaCl (figure 2).
Figure 3 shows mean values and standard deviations of
fibronectin in the plasma specimens of normal persons
10 \\
ι I I I
1:2 1:4 1:8 1:16 1:32 1:64
Antiserum dilution
1:128 1:256
Fig. 1. Dilution curve of a monospecific antiserum (from a self-
prepared antigen) against a human plasma pool con-
taining fibronectin (21 mg/dl). Plasma.pool dilution was
1:10.
U( V] = intensity of the light scattering signal.
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Fig. 2. Dilution curve of a standard plasma (Behring-Werke), con-
taining 25 mg/dl fibronectin. The dilution of the mono-
specific antiserum was 1:5.
U[V] = intensity of the light scattering signal.
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Fig. 3. Preliminary results on fibronectin concentrations
(hatched bars) in the plasma of patients with chronic
active liver diseases (Mean values and standard deviations:
ή ). For comparison the histologically-estimated fibrosis
activity (φ; +; ++) in the liver as well as the serum activity
of N-acetyl-0-glucosaminidase (open bars) from the same
patients are given, η = normal healthy controls.
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(n - 23) and patients with chronic active liver diseases
(n = 79). Our own plasma pool and the available standard
plasma contain nearly the same amounts of fibronectin.
Preliminary results indicate that fibronectin concentra-
tions in plasma specimens of patients with chronic active
liver diseases could be elevated.
Discussion
Determination of fibronectin concentrations in various
biological fluids and supernatants of homogenized tissues
has been reported by only a few authors (1,5,12). The
fact that immunoassays in particular are not used by
other authors for clinical purposes reflects the relative
difficulty in purifying fibronectin and mainly the poor
performance of labeled fibronectin (6). In general a
radioimmunoassay procedure is not necessary to deter-
mine fibronectin in plasma specimens because of its high
concentration. Using the light scattering of immuno-
precipitates, we have established a laser nephelometer
assay that circumvents the problem encountered with
previous methods. Our dilution series and reference
curves show that at the concentrations of antisera and
plasma specimens chosen no significant surplus of either
antiserum or plasma is detectable. The dilution experi-
ments with the antisera show that the concentration
elected for the assay is found in the middle of the right
side of the Heidelberger curve (8).
Our preliminary results show that the fibronectin con-
centrations in the plasma of patients with chronic liver
diseases (fig. 3) may be increased twofold over the mean
value for normal persons or standard plasma. An inter-
pretation of the increased fibronectin concentrations
with respect to the pathogenesis of the mentioned
diseases and the possible clinical implications is difficult
on the basis of these preliminary results.
As demonstrated in figure 3, no relation between fibro-
nectin concentrations in the plasma and the histologically
estimated fibrous activity in the liver tissue could be
detected, whereas the serum activity of N-acetyl-0-
glucosaminidase — as previously reported (9) — is in-
creased in relation to the activity of fibrosis. Further in-
vestigations will be necessary to elucidate the diagnostic
value of determining the fibronectin concentration in
the plasma of patients with liver fibrosis.
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